Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
4.640
+0.110 (2.43%)
At close: Aug 20, 2025, 4:00 PM
4.640
0.00 (0.00%)
After-hours: Aug 20, 2025, 4:00 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $411.90 million as of August 20, 2025. Its market cap has increased by 120.29% in one year.
Market Cap
411.90M
Enterprise Value
281.94M
1-Year Change
120.29%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $411.90M, a decrease of -51.40%. That is a compound annual growth rate of -11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 401.71M | -2.14% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.66B |
| Johnson & Johnson | 426.35B |
| AbbVie | 364.97B |
| UnitedHealth Group | 283.85B |
| AstraZeneca | 243.89B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 228.17B |
| Novo Nordisk | 227.24B |